Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Stroke and CYP3A4[original query] |
---|
Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. Stroke; a journal of cerebral circulation 2008 Aug 39 (8): 2211-8. Yamada Yoshiji, Metoki Norifumi, Yoshida Hidemi, Satoh Kei, Kato Kimihiko, Hibino Takeshi, Yokoi Kiyoshi, Watanabe Sachiro, Ichihara Sahoko, Aoyagi Yukitoshi, Yasunaga Akitomo, Park Hyuntae, Tanaka Masashi, Nozawa Yoshino |
Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart (British Cardiac Society) 2012 Sep 98 (18): 1366-72. Park Kyung Woo, Kang Jeehoon, Park Jin Joo, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Stroke; a journal of cerebral circulation 2013 Jun 44 (6): 1717-9. Jia Dong-mei, Chen Zhi-bin, Zhang Mei-juan, Yang Wen-jie, Jin Jia-li, Xia Yong-quan, Zhang Chun-lei, Shao Yuan, Chen Cong, Xu Y |
The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment. CNS neuroscience & therapeutics 2014 Feb 20 (2): 125-30. Lin Yong-Juan, Li Jing-Wei, Zhang Mei-Juan, Qian Lai, Yang Wen-Jie, Zhang Chun-Lei, Shao Yuan, Zhang Yang, Huang Yu-Jie, Xu Y |
VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke. Thrombosis research 2014 Dec 134 (6): 1272-7. Zhang Shijun, Lai Xinqiang, Li Wenxian, Xiong Zhilin, Xu Anding, Xu Anding, Huang Li' |
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
European heart journal 2015 Aug 36 (29): 1901-12. Varenhorst Christoph, Eriksson Niclas, Johansson Åsa, Barratt Bryan J, Hagström Emil, Åkerblom Axel, Syvänen Ann-Christine, Becker Richard C, James Stefan K, Katus Hugo A, Husted Steen, Steg Ph Gabriel, Siegbahn Agneta, Voora Deepak, Teng Renli, Storey Robert F, Wallentin Lars, |
Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 Sep . Yi Xingyang, Han Zhao, Zhou Qiang, Cheng Wen, Lin Jing, Wang Ch |
Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016 Aug . Yi Xingyang, Zhou Qiang, Wang Chun, Lin Jing, Cheng Wen, Chi Lif |
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Acta pharmacologica Sinica 2016 May . Liu Rui, Zhou Zi-Yi, Chen Yi-Bei, Li Jia-Li, Yu Wei-Bang, Chen Xin-Meng, Zhao Min, Zhao Yuan-Qi, Cai Ye-Feng, Jin Jing, Huang M |
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study. Medicine 2016 Jan 95 (2): e2487. Wang Yi-Chun, Hsieh Tsung-Cheng, Chou Chu-Lin, Wu Jung-Lun, Fang Te-Ch |
Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saedi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population. Clinical therapeutics 2018 Feb . Peng Chen, Ding Ying, Yi Xin, Shen Yupei, Dong Zhiqiang, Cao Limei, Li Qiang, Ren Haiyan, He Lin, Zhou Daizhan, Chen |
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 2019 Sep . Gulilat Markus, Keller Denise, Linton Bradley, Pananos A Demetri, Lizotte Daniel, Dresser George K, Alfonsi Jeffrey, Tirona Rommel G, Kim Richard B, Schwarz Ute |
Association of CYP3A4*1G and CYP3A5*3 With the 1-year Outcome of Acute Ischemic Stroke in the Han Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019 May . Li Shuo, Shi Chang-He, Liu Xin-Jing, Li Yu-Sheng, Li Shao-Hua, Song Bo, Xu Yu-Mi |
Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020 4 26 1076029620909154. Rojo Mario, Roco Angela Margarita, Suarez Marcelo, Lavanderos Maria Alejandra, Verón Gabriel, Bertoglia Maria Paz, Arredondo Annabella, Nieto Elena, Rubilar Juan Carlos, Tamayo Francisca, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Véliz Paulo, Godoy Gerald, Varela Nelson Miguel, Llull G, Quiñones Luis Ab |
CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study. BMC neurology 2020 Mar 20 (1): 77. Gao Ning, Tang Hong, Gao Ling, Tu Guolong, Luo Han, Xia Yi |
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke. PloS one 2020 15 (12): e0236260. Rath Charlotte Lützhøft, Jørgensen Niklas Rye, Wienecke Troe |
Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment. Expert opinion on drug metabolism & toxicology 2021 5 17 (6): 685-695. Alkattan Abdullah, Alsalameen Em |
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study. Frontiers in pharmacology 2022 12 13 1032995. Azzahhafi Jaouad, Bergmeijer Thomas O, van den Broek Wout W A, Chan Pin Yin Dean R P P, Rayhi Senna, Peper Joyce, Bor Willem L, Claassens Daniel M F, van Schaik Ron H N, Ten Berg Jurriën |
Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients. Frontiers in pharmacology 2022 12 13 1007113. Campos-Staffico Alessandra M, Dorsch Michael P, Barnes Geoffrey D, Zhu Hao-Jie, Limdi Nita A, Luzum Jasmine |
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events. Frontiers in genetics 2022 10 13 982955. Attelind Sofia, Hallberg Pär, Wadelius Mia, Hamberg Anna-Karin, Siegbahn Agneta, Granger Christopher B, Lopes Renato D, Alexander John H, Wallentin Lars, Eriksson Nicl |
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: